Robert G Nagele
age ~71
from Blackwood, NJ
- Also known as:
-
- Robert G Wagele
- Rg Nagele
- Phone and address:
-
17 Indian Birch Rd, Blenheim, NJ 08012
(856)2274589
Robert Nagele Phones & Addresses
- 17 Indian Birch Rd, Blackwood, NJ 08012 • (856)2274589
- Turnersville, NJ
- 119 40Th St, Sea Isle City, NJ 08243 • (609)2631745
- 302 40Th St, Sea Isle City, NJ 08243 • (609)2631745
- Piscataway, NJ
- Pine Hill, NJ
- Barrington, NJ
- Stratford, NJ
- Camden, NJ
- Thousand Oaks, CA
- Berlin, NJ
Work
-
Company:University of medicine and dentistry of new jersey
-
Position:Professor of medicine
Industries
Research
Resumes
Professor Of Medicine At University Of Medicine And Dentistry Of New Jersey
view sourcePosition:
Professor of Medicine at University of Medicine and Dentistry of New jersey
Location:
Greater Philadelphia Area
Industry:
Research
Work:
University of Medicine and Dentistry of New jersey
Professor of Medicine
Professor of Medicine
Name / Title
Company / Classification
Phones & Addresses
Professor
Rutgers, The State University of New Jersey
Library Administrative Educational Programs · Medical University Library · Library
Library Administrative Educational Programs · Medical University Library · Library
1 Medical Ctr Dr, Stratford, NJ 08084
(856)5666809, (856)5666800
(856)5666809, (856)5666800
Us Patents
-
Methods Of Treatment And Prevention Of Neurodegenerative Diseases And Disorders
view source -
US Patent:20080279846, Nov 13, 2008
-
Filed:May 12, 2008
-
Appl. No.:12/118973
-
Inventors:Yi SHI - Boothwyn PA, US
Robert NAGELE - Turnersville NJ, US -
Assignee:THOMAS JEFFERSON UNIVERSITY - Philadelphia PA
UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY - New Brunswick NJ -
International Classification:A61K 39/395
A61K 48/00
A61K 31/517
A61K 31/519
A61K 39/00
A61P 25/00
A61K 31/55
A61K 31/4709
A61K 38/02 -
US Classification:4241301, 514 44, 514 2, 5142581, 514312, 5142641, 514215, 4241841
-
Abstract:The present invention provides compostions and methods useful for treating and preventing neurodegenerative disease and neurologically related disorders by inhibition of Lp-PLA2. The compositions and methods are useful for treating and preventing diseases and disorders with abnormal blood brain barrier (BBB) function, for example neurodegenerative diseases with a permeable BBB, such as but not limited to, Alzheimer's Disease, Huntington's Disease, Parkinson's Disease and Vascular Dementia.
-
Methods Of Treatment And Prevention Of Neurodegenerative Diseases And Disorders
view source -
US Patent:20130150379, Jun 13, 2013
-
Filed:Mar 14, 2011
-
Appl. No.:13/047381
-
Inventors:Yi SHI - Boothwyn PA, US
Robert NAGELE - Turnersville NJ, US -
Assignee:UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY - New Brunswick NJ
THOMAS JEFFERSON UNIVERSITY - Philadelphia PA -
International Classification:A61K 31/517
-
US Classification:5142581
-
Abstract:The present invention provides compostions and methods useful for treating and preventing neurodenerative disease and neurologically related disorders by inhibition of Lp-PLA2. The compositions and methods are useful for treating and preventing diseases and disorders with abnormal blood brain barrier (BBB) function, for example neurodegenerative diseases with a permeable BBB, such as but not limited to, Alzheimer's Disease, Huntington's Disease, Parkinson's Disease and Vascular Dementia.
-
Diagnostic Autoantibody Profiles For The Detection And Diagnosis Of Neurodegenerative Diseases
view source -
US Patent:20130157888, Jun 20, 2013
-
Filed:Apr 1, 2011
-
Appl. No.:13/697601
-
Inventors:Robert G. Nagele - Turnersville NJ, US
-
Assignee:UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY - Somerset NJ
-
International Classification:G01N 33/68
-
US Classification:506 9, 435 792, 506 18
-
Abstract:The present invention provides methods, compositions, and kits for the detection of neurodegenerative disease specific autoantibodies for the diagnosis of neurodegenerative diseases and risk for developing neurodegenerative diseases, and for the generation of patient-specific neurodegenerative disease diagnostic autoantibody profiles.
-
Diagnostic Biomarkers For Detecting, Subtyping, And/Or Assessing Progression Of Multiple Sclerosis
view source -
US Patent:20220390447, Dec 8, 2022
-
Filed:Aug 18, 2022
-
Appl. No.:17/820803
-
Inventors:- Glassboro NJ, US
Robert G. Nagele - Turnersville NJ, US -
International Classification:G01N 33/564
G01N 33/552
G01N 33/53 -
Abstract:Disclosed are methods, compositions and kits for detecting Multiple Sclerosis (MS) as well as for distinguishing relapsing-remitting (RRMS) and secondary progressive (SPMS) MS subtypes with high overall accuracy. Autoantibody antigens and biomarkers, for the diagnosis of MS in general, RRMS and SPMS, as well as for the identification of a subject at risk for developing MS, and for the generation of patient-specific MS autoantibody biomarker profiles are also provided.
-
Diagnostic Biomarkers For Detecting, Subtyping, And/Or Assessing Progression Of Multiple Sclerosis
view source -
US Patent:20220390448, Dec 8, 2022
-
Filed:Aug 18, 2022
-
Appl. No.:17/820815
-
Inventors:- Glassboro NJ, US
Robert G. Nagele - Turnersville NJ, US -
International Classification:G01N 33/564
G01N 33/552
G01N 33/53 -
Abstract:Disclosed are methods, compositions and kits for detecting Multiple Sclerosis (MS) as well as for distinguishing relapsing-remitting (RRMS) and secondary progressive (SPMS) MS subtypes with high overall accuracy. Autoantibody antigens and biomarkers, for the diagnosis of MS in general, RRMS and SPMS, as well as for the identification of a subject at risk for developing MS, and for the generation of patient-specific MS autoantibody biomarker profiles are also provided.
-
Diagnostic Biomarkers For Detecting, Subtyping, And/Or Assessing Progression Of Multiple Sclerosis
view source -
US Patent:20210003570, Jan 7, 2021
-
Filed:May 10, 2018
-
Appl. No.:16/611951
-
Inventors:- Glassboro NJ, US
Robert G. Nagele - Turnersville NJ, US -
International Classification:G01N 33/564
G01N 33/552 -
Abstract:Disclosed are methods, compositions and kits for detecting Multiple Sclerosis (MS) as well as for distinguishing relapsing-remitting (RRMS) and secondary progressive (SPMS) MS subtypes with high overall accuracy. Autoantibody antigens and biomarkers, for the diagnosis of MS in general, RRMS and SPMS, as well as for the identification of a subject at risk for developing MS, and for the generation of patient-specific MS autoantibody biomarker profiles are also provided.
-
Early-Stage Alzheimer's Disease Autoantibody Biomarkers, Target Antigens And Diagnostic Uses Thereof
view source -
US Patent:20200340990, Oct 29, 2020
-
Filed:Dec 14, 2016
-
Appl. No.:16/061534
-
Inventors:- GLASSBORO NJ, US
ROBERT G. NAGELE - TURNERSVILLE NJ, US -
International Classification:G01N 33/564
G01N 33/68 -
Abstract:The present invention provides methods, compositions, and kits for the detection of Early-Stage Alzheimer's disease (AD) autoantibody biomarkers, for the diagnosis of Early-Stage AD, for the identification of a subject at risk for developing Early-Stage AD, and/or for the generation of patient-specific Early-Stage AD autoantibody biomarker profiles.
-
Diagnostic Biomarker Profiles For The Detection And Diagnosis Of Alzheimer's Disease
view source -
US Patent:20200309795, Oct 1, 2020
-
Filed:Jun 16, 2020
-
Appl. No.:16/902829
-
Inventors:- Glassboro NJ, US
Robert G. Nagele - Turnersville NJ, US -
International Classification:G01N 33/68
G01N 33/564 -
Abstract:The present invention provides methods, compositions and kits for the detection of Alzheimer's disease (AD) diagnostic biomarkers, for the diagnosis of AD, for the identification of a subject at risk for developing AD, and for the generation of patient-specific AD diagnostic biomarker profiles.
Classmates
Haverford College, Haverf...
view sourceGraduates:
Robert Nagele (1971-1975),
Laura Howson (1995-1999),
Colleen Ward (1998-2002),
Jeffrey Bendix (1972-1976)
Laura Howson (1995-1999),
Colleen Ward (1998-2002),
Jeffrey Bendix (1972-1976)
Conestoga High School, Be...
view sourceGraduates:
Robert Nagele (1970-1971),
Jennie Dewees (1972-1976),
Sandee McHale (1971-1975),
Vanessa Justis (1993-1997),
Kelly Delaney (1988-1992)
Jennie Dewees (1972-1976),
Sandee McHale (1971-1975),
Vanessa Justis (1993-1997),
Kelly Delaney (1988-1992)
Lahser High School, Bloom...
view sourceGraduates:
Robert Nagele (1967-1971)
Youtube
Myspace
Robert Nagele
view sourceBirthday:
1954
News
Blood Test to Detect Early Alzheimer's Disease Nearly 100 Percent Accurate
view source- n a press release, about the discovery of the blood test, lead researcher Dr. Robert Nagele from Rowan University School of Osteopathic Medicine said that it is now believed that changes in a persons brain begin at least a decade prior to certain telltale symptoms of Alzheimers disease appear. Acc
- Date: Jun 11, 2016
- Category: Health
- Source: Google
First blood test to use autoantibody biomarkers to detect early-stage Alzheimer's with 100% accuracy rate
view source- Studys lead researcher Dr. Robert Nagele said that this is the first blood test that uses autoantibody biomarkers to detect Alzheimers at an early stage with great efficacy level. It would also be the time when treatments are more likely to be beneficial.
- Date: Jun 11, 2016
- Category: Health
- Source: Google
New Blood Test Could Detect Early Stages of Alzheimer's
view source- Dr. Robert Nagele, the research team leader, said the results now being reported were particularly important because pre-Alzheimer's changes in the brain begin "at least a decade before the emergence of telltale symptoms.
- Date: Jun 09, 2016
- Category: Health
- Source: Google
Blood Test Can Detect Alzheimer's At Early Stage
view source- Robert Nagele, Ph.D., presenter of the latest findings at the Osteopathic Medical Conference and Exposition (OMED 15) in Orlando, has worked on autoanitibodies as primary biomarkers to indicate the presence of a disease and its stage. He foresees the benefit of early Alzheimer's disease detection as
- Date: Oct 19, 2015
- Category: Health
- Source: Google
Blood Test May Spot Alzheimer's Before Symptoms Appear
view source- ''This is a simple test that has high accuracy and can be run from a single drop of blood," says Robert Nagele, PhD, a professor of medicine at the University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine. He is also founder of Durin Technologies Inc., the company that is de
- Date: Aug 04, 2011
- Category: Health
- Source: Google
Robert Nagele
view sourceGet Report for Robert G Nagele from Blackwood, NJ, age ~71